• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

CheqUp and WeightWatchers to Enhance GLP-1 Weight Loss Journeys in UK with Integrated Support

by Jasmine Pennic 05/27/2025 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

What You Should Know: 

– CheqUp, one of the UK’s leading providers of GLP-1 based weight loss services, and WeightWatchers, the global leader in science-backed weight management announced a new partnership. 

– The collaboration will combine the offerings of both organizations to benefit patients in the UK seeking sustainable weight loss through GLP-1 medication coupled with comprehensive behavioural support.

A Holistic Approach to GLP-1 Supported Weight Loss

The partnership aims to deliver a seamless solution by integrating CheqUp’s human-centric approach to prescribed weight loss medication—which includes dedicated clinical support and live, one-to-one health coaching—with WeightWatchers’ science-backed GLP-1 Companion Programme. This programme provides tailored nutritional and behavioural lifestyle support specifically for individuals on GLP-1 medications. Together, these complementary offerings are designed to provide a more effective solution to weight management, helping members achieve better results than with medication alone.

This collaboration addresses the growing demand in the UK market, where an estimated 12 million people qualify for prescription GLP-1 medications. The UK Government is also currently examining the case for a wider rollout of these medications, recognizing their significant potential to improve health and impact work productivity. The CheqUp and WeightWatchers partnership offers a holistic model of care for those currently using, or considering, GLP-1 medication.

Enhanced Resources for CheqUp Members

Through this partnership, CheqUp members who pursue their weight loss journey with GLP-1 medications will now receive the following tools and resources from WeightWatchers’ GLP-1 Companion Programme, at no additional cost:

  • Nutritional guidance from experts: This includes access to GLP-1 “go-to” food recommendations designed to guide decisions towards more nutrient-dense foods that can help minimize side effects and support healthy weight loss.
  • A simple tracking experience: Members will be supported with three daily nutrition targets focusing on protein, fruits and vegetables, and hydration.
  • Judgement-free support: Access to WeightWatchers’ vibrant members-only social network groups, where individuals can connect, share nutrition and activity insights, and receive invaluable emotional support from others on a similar GLP-1 journey.
  • A comprehensive progress overview: Tools to track weight loss, identify trends, and provide a clear roadmap for future success.

“We are delighted that WeightWatchers chose CheqUp to be its strategic partner when it comes to holistic healthcare in the GLP-1 category,” said James Hunt, Deputy CEO of CheqUp. “We are seeing exponential growth in the number of people who are choosing CheqUp to help them through what is a sometimes difficult but incredibly rewarding journey of weight loss. There is no doubt that the addition of WeightWatchers’ breakthrough GLP-1 companion programme will add enormously to our patients’ ability to achieve sustainable weight loss through its science-backed and proven programmes, together with their global community of like-minded individuals. We are proud that WeightWatchers has put their trust in our human-centric approach and access to the expertise of our clinicians and Health Coaches. This partnership offers the most attractive proposition in the market for those looking to benefit from the incredible potential of GLP-1 medications and behaviour change”.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: GLP-1

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

Aligning IT & Clinical Teams: How to Reduce Friction and Improve Communication

Most-Read

CB Insights Q2 2026 State of Digital Health Report: Fewest Deals in Over a Decade as Median Sizes Rise

CB Insights Q2 2026 State of Digital Health Report: Fewest Deals in Over a Decade as Median Sizes Rise

mount-sinai-launches-epic-chart-with-art-nursing-ambient-ai

Mount Sinai Medical Center Extends Epic’s Ambient AI to Inpatient Nursing

M&A: Tempus AI to Acquire Personalis for $1.5B to Expand Precision Oncology and MRD Monitoring

M&A: Tempus AI to Acquire Personalis for $1.5B to Expand Precision Oncology and MRD Monitoring

Why Brain Health Is Entering Its Infrastructure Era

Brain Health’s Infrastructure Era: Proving Clinical Outcomes with Integrated Neuromotor Tracking

Why Catholic Health Inked a $500M Care Alliance with GE HealthCare to Automate Outpatient Triage

Catholic Health Inks $500M Care Alliance with GE HealthCare to Automate Outpatient Triage

KLAS Global HIT Trends 2026 Report: Artificial Intelligence Becomes the Top Investment Priority

KLAS Global HIT Trends 2026 Report: Artificial Intelligence Becomes the Top Investment Priority

Optum Partners with Anthropic to Deploy Claude Across Healthcare Claims and Revenue Workflows

Optum Partners with Anthropic to Deploy Claude Across Healthcare Claims and Revenue Workflows

Rock Health H1 2026 Digital Health Funding Recap: Startups Hit $7.4B in Venture Rebound

Rock Health H1 2026 Digital Health Funding Recap: Startups Hit $7.4B in Venture Rebound

M&A: ResMed to Sell MatrixCare Business to Frazier Healthcare Partners for $450M

M&A: ResMed to Sell MatrixCare Business to Frazier Healthcare Partners for $450M

The Real Risk in Healthcare AI Isn’t the Model. It’s the Data. 

Clinical Data Fidelity: The Real Blindspot in Healthcare AI Strategy

Secondary Sidebar

Footer

Company

  • About Us
  • 2026 Editorial Calendar
  • Advertise with Us
  • Reprints and Permissions
  • Op-Ed Submission Guidelines
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2026. HIT Consultant Media. All Rights Reserved. Privacy Policy |